We want to eliminate the high cost, low access and lengthy time frame for comprehensive cardiac assessment.
Cardiac and pulmonary disease is progressive. Yet people who are suffering from these conditions are normally forced to wait weeks, months or even years for accurate diagnosis and treatment.
Patients and families are left hanging, and treatments are ultimately more serious and costly as a result.
Globally millions of people are pushed into extreme poverty every year because of health expenses.
In the US alone, the direct medical cost of heart disease is projected to reach 750 billion per year.
Cardiovascular disease is a major cause of widening inequity in health outcomes between the rich and poor, cities and rural areas.
It’s currently estimated that 90 million North Americans suffer from undiagnosed heart conditions.
Heart disease results
in 32% of all global
disease has grown
40% and keeps
At Sparrow, we are a team of engineers, doctors and product people that share the commitment to deliver disease detection at scale.
We offer a new way to capture and process biological signals aimed at removing barriers for patients and lowering costs for providers.